BNP Paribas Financial Markets’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80 | Hold |
|
|||||
|
2025
Q1 | $89 | Sell |
|
|||||
|
2024
Q4 | $868 | Sell |
|
|||||
|
2024
Q3 | $27.1K | Sell |
|
|||||
|
2024
Q2 | $350K | Buy |
|
|||||
|
2024
Q1 | $61.3K | Sell |
|
|||||
|
2023
Q4 | $69.1K | Sell |
|
|||||
|
2023
Q3 | $193K | Buy |
|
|||||
|
2023
Q2 | $466K | Sell |
|
|||||
|
2023
Q1 | $2.12M | Buy |
|
|||||
|
2022
Q4 | $760K | Sell |
|
|||||
|
2022
Q3 | $638K | Sell |
|
|||||
|
2022
Q2 | $831K | Sell |
|
|||||
|
2022
Q1 | $1.74M | Buy |
|
|||||
|
2021
Q4 | $1.36M | Buy |
|
|||||
|
2021
Q3 | $767K | Buy |
|
|||||
|
2021
Q2 | $519K | Buy |
|
|||||
|
2021
Q1 | $386K | Buy |
|
|||||
|
2020
Q4 | $64.4K | Sell |
|
|||||
|
2020
Q3 | $131K | Buy |
|
|||||
|
2020
Q2 | $118K | Buy |
|
|||||
|
2020
Q1 | $46.7K | Buy |
|
|||||
|
2019
Q4 | $13K | Buy |
|
|||||
|
2019
Q3 | $2.1K | Buy |
|
|||||
|
2019
Q2 | $175 | Buy |
|